共 50 条
Proton-Pump Inhibitor as Palliative Care for Chemotherapy-Induced Gastroesophageal Reflux Disease in Pancreatic Cancer Patients
被引:11
|作者:
Uwagawa, Tadashi
[1
]
Misawa, Takeyuki
[1
]
Iida, Tomonori
[1
]
Sakamoto, Taro
[1
]
Gocho, Takeshi
[1
]
Wakiyama, Shigeki
[1
]
Hirohara, Shoichi
[1
]
Yanaga, Katsuhiko
[1
]
机构:
[1] Jikei Univ, Sch Med, Dept Surg, Tokyo, Japan
关键词:
RECOMMENDATIONS;
GUIDELINES;
THERAPY;
D O I:
10.1089/jpm.2009.0404
中图分类号:
R19 [保健组织与事业(卫生事业管理)];
学科分类号:
摘要:
Relief of adverse events induced by chemotherapy is an important issue for patients, especially those with a poor prognosis, such as with pancreatic cancer. There are no reports of the relationship between gastroesophageal reflux disease (GERD) and chemotherapy, so we investigated the incidence of chemotherapy-induced GERD in patients undergoing treatment with gemcitabine or S-1 for pancreatic cancer and the effect of sodium rabeprazole (RPZ), a proton-pump inhibitor. GERD was diagnosed in 40% of the patients according to the Frequency Scale for Symptoms of GERD score, and RBZ therapy significantly improved their symptoms.
引用
收藏
页码:815 / 818
页数:4
相关论文